|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Toxicity and response criteria of the Eastern Cooperative Oncology Group显示文摘 | Oken MM Creech RH Tormey DC | | 0，，： | 1 |
| 2 | Myeloma and the t( 11; 14) (q13;q32); evidence for a biologically defined unique subset ofpatients显示文摘 | Fonseca R Blood EA Oken MM | 2002 | Blood2002，99，10： | 1 |
| 3 | Toxicity and response criteria of the eastern cooperative oncology group显示文摘 | Oken MM Creech RH Tormey DC | 1982 | Am J Clin Oncol1982，5，6： | 1 |
| 4 | Toxicity and re-sponse criteria of the eastern cooperative oncology group显示文摘 | Oken MM Creech RH Tormey DC | 1982 | Am J Clin Oncol1982，5，6： | 1 |
| 5 | Biological and prognostic significance of interphase fluorescence in situ hy- bridization detection of chromosome 13 abnormalities (delta13) in muhiple myeloma: an eastern cooperative on- cology group study 显示文摘 | Fonseca R Harrington D Oken MM | 2002 | Cancer Research2002，62，3： | 1 |
| 6 | Toxicity and responsecriteria of the Eastern Cooperative Oncology Group显示文摘 | Oken MM Creech RH Tormey DC | 1982 | Am JClin Oncol1982，5，6： | 1 |
| 7 | Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial 显示文摘 | Oken MM Hocking WG Kvale PA | 2011 | JAMA2011，306，17： | 1 |
| 8 | Screening by chest radiograph and lungcancer mortality: the Prostate,Lung, Colorectal, and Ovarian (PLCO) randomized trial 显示文摘 | Oken MM Hocking WG Kvale PA PLCO Project Team | 2011 | JAMA2011，306，17： | 1 |
| 9 | Toxicity and response criteria of the Eastern Cooperative Oncology Group显示文摘 | Oken MM Creech RH Tormey DC | 1982 | Am J Clin Oncol1982，5，： | 1 |
| 10 | Phase Ⅰ study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma:results and and long-term follow-up- a report from the Eastern Cooperative Oncology Group 显示文摘 | Hochster HS Oken MM Winter JN | 2000 | J Clin Oncol2000，18，5： | 1 |
| 11 | Toxicity and re-sponse criteria of the Eastern Cooperative Oncology Group显示文摘 | Oken MM Creech RH Torraey DC | 1982 | Am J Clin Oncol1982，5，6： | 1 |
| 12 | Toxici- ty and response criteria of the Eastern Coopera- tive Oncology Group显示文摘 | Oken MM Creech RH Tormey DC | 1982 | Am J Clin Oncol1982，5，6： | 1 |
| 13 | Toxicity and response criteria of the Eastern Cooperative Oncology Group显示文摘 | Oken MM Creech RH Tormey DC Horton J Davis TE McFadden ET Carbone PP | | 0，，06： | 1 |
| 14 | Toxicity and response criteria of the Eastern Cooperative Oncology Group显示文摘 | Oken MM Creech RH Tormey DC | | 0，，： | 1 |
| 15 | Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Co显示文摘 | Oken MM Hocking WG Kvale PA | 2011 | Jama2011，306，17： | 1 |
| 16 | Lung cancer screening in the randomized prostate, lung, colorectal, and ovarian (PLCO) screen- ing trial 显示文摘 | Hocking WG Hu P Oken MM | 2010 | J Natl Cancer Inst2010，102，10： | 1 |
| 17 | Toxicity and response criteria of the Eastern Cooperative Oncology Group 显示文摘 | Oken MM Creech RH Tormey DC | 1982 | Am J ClinOncol1982，5，： | 1 |
| 18 | Toxici- ty and response criteria of the Eastern Coopera- tive Oncology Group显示文摘 | Oken MM Creech RH Tormey DC | 1982 | Am J Clin Oncol1982，5，5： | 1 |
| 19 | Phase 1 study of fludarabine plus eyelophosphamide in previously untreated low - grade lymphoma: results and long - term follow - up - a report from the eastern cooperative Ontology Group 显示文摘 | Hochster HS Oken MM Winter JN | 2000 | J Clin Oneol2000，18，5： | 1 |
| 20 | Toxicity and response criteria of the Eastern Cooperative Oncology Group 显示文摘 | Oken MM Creeeh RH Tormet DC | 1982 | Am J Clin Oncol1982，5，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员